{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:13:14Z","timestamp":1789038794696,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet. Sci.","Veterinary Sciences"],"abstract":"<jats:p>This retrospective study described clinical outcomes of combining local recombinant feline interferon-omega (rFeIFN-\u03c9) injection with oral prednisolone in the management of canine aural hematoma. The medical records of dogs presented to a private veterinary hospital between January 2019 and January 2026 were reviewed. Thirty-one dogs underwent the treatment protocol, of which five were lost to follow-up, leaving a final cohort of 26 dogs. The protocol involved a local intralesional injection of 10.0 MU of rFeIFN-\u03c9 without fluid evacuation alongside concurrent oral prednisolone (1.0 mg\/kg once daily) without anesthesia at 1-week intervals. Complete initial resolution was achieved in 21 dogs (80.8%) with a mean of 2.37 \u00b1 1.14 treatment sessions, whereas 5 dogs discontinued therapy prematurely prior to complete resolution because the owners declined further treatment visits, leaving their final outcomes undetermined. Recurrence was documented in five of the 21 complete resolution cases (23.8%), spanning from 2 weeks to 1 year post-resolution. Two of these dogs underwent re-treatment and achieved complete clinical resolution during the available follow-up period. No clinically relevant adverse effects occurred. While the independent therapeutic efficacy of rFeIFN-\u03c9 remains unproven, these preliminary findings suggest that the combination protocol may represent a feasible, non-surgical outpatient option for managing canine aural hematoma.<\/jats:p>","DOI":"10.3390\/vetsci13090937","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:27:21Z","timestamp":1789036041000},"page":"937","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of the Combination Therapy of Recombinant Feline Interferon-Omega Injection and Oral Prednisolone for Canine Aural Hematoma: A Retrospective Case Series"],"prefix":"10.3390","volume":"13","author":[{"given":"Tomoya","family":"Furujo","sequence":"first","affiliation":[{"name":"Animal Medical Center, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-9006","authenticated-orcid":false,"given":"Masayoshi","family":"Nagakawa","sequence":"additional","affiliation":[{"name":"Animal Medical Center, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-695X","authenticated-orcid":false,"given":"Kazumi","family":"Shimada","sequence":"additional","affiliation":[{"name":"Animal Medical Center, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Takashimadaira Tezuka Animal Hospital, Tokyo 175-0082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Tezuka","sequence":"additional","affiliation":[{"name":"Takashimadaira Tezuka Animal Hospital, Tokyo 175-0082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-1889","authenticated-orcid":false,"given":"Daisuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, Texas A&M University, College Station, TX 77843, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2844-2356","authenticated-orcid":false,"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Animal Medical Center, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21670","DOI":"10.1038\/s41598-021-00352-0","article-title":"Reporting the Epidemiology of Aural Haematoma in Dogs and Proposing a Novel Aetiopathogenetic Pathway","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2327\/jvas.36.87","article-title":"Epidemiological and Etiological Studies on 59 Aural Hematomas of 49 Dogs","volume":"36","author":"Mikawa","year":"2005","journal-title":"Jpn. J. Vet. Anesth. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jsap.12524","article-title":"Treatment of Canine Aural Haematoma by UK Veterinarians","volume":"57","author":"Hall","year":"2016","journal-title":"J. Small Anim. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2460\/ajvr.1986.47.10.2300","article-title":"Canine and Feline Aural Hematoma: Clinical, Experimental, and Clinicopathologic Observations","volume":"47","author":"Kuwahara","year":"1986","journal-title":"Am. J. Vet. Res."},{"key":"ref_5","first-page":"313","article-title":"Aural Hematoma and It\u2019s Treatment: A Review","volume":"61","author":"Hewitt","year":"2020","journal-title":"Can. Vet. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2460\/javma.1984.185.08.873","article-title":"Pathogenesis of Canine Aural Hematomas","volume":"185","author":"Dubielzig","year":"1984","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1748-5827.1994.tb01711.x","article-title":"Treatment of Canine Aural Haernatorna Using an Indwelling Drain and Corticosteroids","volume":"35","author":"Joyce","year":"1994","journal-title":"J. Small Anim. Pract."},{"key":"ref_8","first-page":"44","article-title":"A Preliminary Report on Aural Hematoma Management with Auricular Pillow Method","volume":"11","author":"Eyarefe","year":"2013","journal-title":"Glob. Vet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2460\/javma.246.1.112","article-title":"Use of Laterally Placed Vacuum Drains for Management of Aural Hematomas in Five Dogs","volume":"246","author":"Pavletic","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Perego, R., Spada, E., Moneta, E., Baggiani, L., and Proverbio, D. (2021). Use of Autologous Leucocyte- and Platelet-Rich Plasma (L-PRP) in the Treatment of Aural Hematoma in Dogs. Vet. Sci., 8.","DOI":"10.3390\/vetsci8090172"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.17236\/sat00358","article-title":"Non-Blinded Treatment of Aural  hematoma with Oral Prednisolone as a Monotherapy in Privately-Owned Dogs","volume":"164","author":"Schellenberg","year":"2022","journal-title":"Schweiz Arch Tierheilkd"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","article-title":"The Multiple Roles of Interferon Regulatory Factor Family in Health and Disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.intimp.2017.08.028","article-title":"Interferon-Omega: Current Status in Clinical Applications","volume":"52","author":"Li","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1292\/jvms.55.1","article-title":"Pharmacokinetic Properties of Recombinant Feline Interferon and Its Stimulatory Effect on 2\u2032, 5\u2032-Oligoadenylate Synthetase Activity in the Cat","volume":"55","author":"Ueda","year":"1993","journal-title":"J. Vet. Med. Sci."},{"key":"ref_15","first-page":"130","article-title":"Treatment of Canine Parovirus Infection with Recombinant Feline Interferon-\u03c9","volume":"1","author":"Uchino","year":"2008","journal-title":"J. Vet. Clin. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-1135(02)00173-6","article-title":"Treatment of Canine Parvoviral Enteritis with Interferon-Omega in a Placebo-Controlled Challenge Trial","volume":"89","author":"Martin","year":"2002","journal-title":"Vet. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1292\/jvms.60.911","article-title":"Clinical Effects of the Recombinant Feline Interferon-\u03c9 on Experimental Parvovirus Infection in Beagle Dogs","volume":"60","author":"Ishiwata","year":"1998","journal-title":"J. Vet. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1348-0421.2006.tb03828.x","article-title":"Immunological Effects of Recombinant Feline Interferon-\u03c9 (KT-80) Administration in the Dog","volume":"50","author":"Kuwabara","year":"2006","journal-title":"Microbiol. Immunol."},{"key":"ref_19","first-page":"477","article-title":"Therapeutic Effects of Recombinant Feline Interferon-Co on Feline Leukemia Virus (FeLV)-Infected and FeLV\/Feline Immunodeficiency Virus (FIV)-Coinfected Symptomatic Cats","volume":"18","author":"Maynard","year":"2004","journal-title":"J. Vet. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-1135(99)00087-5","article-title":"Feline Interferon-Omega Treatment on Canine Parvovirus Infection","volume":"69","author":"Minagawa","year":"1999","journal-title":"Vet. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5829.2009.00192.x","article-title":"Effect of Recombinant Feline Interferon-\u03c9 Alone and in Combination with Chemotherapeutic Agents on Putative Tumour-initiating Cells and Daughter Cells Derived from Canine and Feline Mammary Tumours","volume":"7","author":"Penzo","year":"2009","journal-title":"Vet. Comp. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cyto.2016.05.018","article-title":"Cytotoxic Effects Induced by Interferon-\u03c9 Gene Lipofection through ROS Generation and Mitochondrial Membrane Potential Disruption in Feline Mammary Carcinoma Cells","volume":"84","author":"Villaverde","year":"2016","journal-title":"Cytokine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0034-5288(95)90017-9","article-title":"In Vitro Growth Inhibition Activities of Recombinant Feline Interferon on All Lines Derived from Canine Tumours","volume":"59","author":"Tateyama","year":"1995","journal-title":"Res. Vet. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Palagiano, P., Graziano, L., Scarabello, W., Berni, P., Andreoli, V., and Grolli, S. (2023). Platelet- Rich Plasma Treatment Supported by Ultrasound Detection of Septa in Recurrent Canine Aural Hematoma: A Case Series. Animals, 13.","DOI":"10.3390\/ani13152456"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1939-1676.2007.tb01957.x","article-title":"Adjuvant Immunotherapy of Feline Fibrosarcoma with Recombinant Feline Interferon-\u03c9","volume":"21","author":"Hampel","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1034\/j.1398-9995.2001.00001.x","article-title":"Molecular Mechanisms of Corticosteroids in Allergic Diseases","volume":"56","author":"Barnes","year":"2001","journal-title":"Allergy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/vec.12603","article-title":"A Review of Associated Controversies Surrounding Glucocorticoid Use in Veterinary Emergency and Critical Care","volume":"27","author":"Aharon","year":"2017","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Olivry, T., DeBoer, D.J., Favrot, C., Jackson, H.A., Mueller, R.S., Nuttall, T., Pr\u00e9laud, P., and International Committee on Allergic Diseases of Animals (2015). Treatment of Canine Atopic Dermatitis: 2015 Updated Guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet. Res., 11.","DOI":"10.1186\/s12917-015-0514-6"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/inp.i1951","article-title":"Successful Management of Otitis Externa","volume":"38","author":"Nuttall","year":"2016","journal-title":"Practice"},{"key":"ref_30","first-page":"97","article-title":"Canine Otitis Externa\u2014Treatment and Complications","volume":"60","author":"Bajwa","year":"2019","journal-title":"Can. Vet. J."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/9\/937\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:54:58Z","timestamp":1789037698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/9\/937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vetsci13090937"],"URL":"https:\/\/doi.org\/10.3390\/vetsci13090937","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}